Department of Nanomedicine & Drug Targeting, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands.
Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands.
ACS Biomater Sci Eng. 2021 Dec 13;7(12):5573-5584. doi: 10.1021/acsbiomaterials.1c00804. Epub 2021 Nov 11.
The formation of the biomolecule corona on the surface of nanoparticles upon exposure to biological fluids critically influences nanocarrier performance in drug delivery. It has been shown that in some cases corona proteins can mediate specific nanoparticle interactions with cell receptors. Within this context, in order to identify corona proteins affecting nanoparticle uptake, in this work, correlation analysis is performed between the corona composition of a panel of silica nanoparticles of different sizes and surface functionalities and their uptake in four endothelial cell types derived from different organs. In this way, proteins that correlate with increased or decreased uptake were identified, and their effects were validated by studying the uptake of nanoparticles coated with a single protein corona and competition studies in brain and liver endothelium. The results showed that precoating nanoparticles with histidine-rich glycoprotein (HRG) alone strongly decreased uptake in both liver and brain endothelium. Furthermore, our results suggested the involvement of the transferrin receptor in nanoparticle uptake in liver endothelium and redirection of the nanoparticles to other receptors with higher uptake efficiency when the transferrin receptor was blocked by free transferrin. These data suggested that changes in the cell microenvironment can also affect nanoparticle uptake and may lead to a different interaction site with nanoparticles, affecting their uptake efficiency. Overall, correlating the composition of the protein corona and nanoparticle uptake by cells allows for the identification of corona molecules that can be used to increase as well as to reduce nanoparticle uptake by cells.
生物分子冠在纳米粒子表面的形成在生物流体中的暴露会极大地影响药物输送中纳米载体的性能。已经表明,在某些情况下,冠蛋白可以介导纳米粒子与细胞受体的特定相互作用。在这种情况下,为了确定影响纳米粒子摄取的冠蛋白,在这项工作中,对一组不同大小和表面功能的二氧化硅纳米粒子的冠组成与它们在四种不同器官来源的内皮细胞中的摄取进行了相关分析。通过这种方式,确定了与摄取增加或减少相关的蛋白质,并通过研究用单一冠蛋白包被的纳米粒子的摄取和脑和肝内皮中的竞争研究来验证它们的作用。结果表明,仅用富含组氨酸的糖蛋白 (HRG) 预先包被纳米粒子就强烈降低了肝和脑内皮细胞的摄取。此外,我们的结果表明,转铁蛋白受体参与了肝内皮细胞中纳米粒子的摄取,并且当转铁蛋白受体被游离转铁蛋白阻断时,将纳米粒子重新导向具有更高摄取效率的其他受体。这些数据表明,细胞微环境的变化也会影响纳米粒子的摄取,并且可能导致与纳米粒子的不同相互作用位点,影响它们的摄取效率。总体而言,将蛋白冠的组成与细胞对纳米粒子的摄取相关联,可以鉴定出可以用于增加和减少细胞对纳米粒子摄取的冠分子。